Semaglutide is not a suitable treatment for everyone
Sodium, potassium, and magnesium levels can drop, causing cramps, fatigue, and heart palpitations
Potentially first-in-Class Anti-Myostatin Approach: Blocks myostatin (GDF8), a negative regulator of muscle growth, to preserve and enhance lean mass
Approximately 51-55% of participants across the Tirzepatide dose groups achieved fibrosis improvement, compared to just 30% in the placebo group
Semaglutide GLP-1 has been highly successful in helping individuals achieve significant weight loss, with many patients experiencing transformative results that greatly enhance their quality of life
During follow-up, the endocrinologist is responsible for monitoring vital signs (e.g